Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
4 | 4 | PSYCHIATRY//PSYCHOLOGY, CLINICAL//PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | 1867560 |
50 | 3 | PSYCHIATRY//SCHIZOPHRENIA//PSYCHIAT | 98837 |
347 | 2 | ANTIDEPRESSANTS//PSYCHIATRY//DEPRESSION | 18063 |
11295 | 1 | VENLAFAXINE//MILNACIPRAN//DULOXETINE | 1020 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | VENLAFAXINE | authKW | 1627875 | 20% | 25% | 208 |
2 | MILNACIPRAN | authKW | 858864 | 8% | 34% | 81 |
3 | DULOXETINE | authKW | 832592 | 13% | 21% | 130 |
4 | DESVENLAFAXINE | authKW | 681050 | 4% | 57% | 39 |
5 | O DESMETHYLVENLAFAXINE | authKW | 643685 | 2% | 83% | 25 |
6 | DULOXETINE HYDROCHLORIDE | authKW | 217556 | 1% | 54% | 13 |
7 | LEVOMILNACIPRAN | authKW | 137628 | 1% | 64% | 7 |
8 | SNRI | authKW | 121543 | 2% | 18% | 22 |
9 | VENLAFAXINE XR | authKW | 118823 | 1% | 38% | 10 |
10 | SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITOR | authKW | 108134 | 1% | 50% | 7 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Psychiatry | 15036 | 44% | 0% | 446 |
2 | Pharmacology & Pharmacy | 6723 | 47% | 0% | 483 |
3 | Clinical Neurology | 783 | 13% | 0% | 136 |
4 | Psychology, Clinical | 606 | 6% | 0% | 60 |
5 | Chemistry, Analytical | 347 | 9% | 0% | 95 |
6 | Psychology | 315 | 4% | 0% | 44 |
7 | Chemistry, Medicinal | 173 | 5% | 0% | 47 |
8 | Biochemical Research Methods | 160 | 5% | 0% | 52 |
9 | Medicine, Legal | 142 | 1% | 0% | 14 |
10 | Neurosciences | 142 | 9% | 0% | 96 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | GLOBAL PHARMACOKINET PHARMACODYNAM TRIAL SIMULAT | 92692 | 0% | 100% | 3 |
2 | MED ABT NEUROL PSYCHIAT | 92692 | 0% | 100% | 3 |
3 | ENSINO PESQUISA CONTROLE QUALIDADE MEDICAME | 61795 | 0% | 100% | 2 |
4 | PFIZER GEP | 61795 | 0% | 100% | 2 |
5 | PHARMACEUT SCIPHARMACOTOXICOL ANAL | 61795 | 0% | 100% | 2 |
6 | ABT MED WISSEN | 41195 | 0% | 67% | 2 |
7 | ACT PHARMACEUT INGREDIENTS IPDO | 30897 | 0% | 100% | 1 |
8 | ADOLESCENT PSYCHIAT PROGRAM | 30897 | 0% | 100% | 1 |
9 | AFFILIATE ACTAVIS INC | 30897 | 0% | 100% | 1 |
10 | ASIA PACIFIC NEUROSCI | 30897 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 39832 | 5% | 3% | 49 |
2 | HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL | 13763 | 3% | 2% | 28 |
3 | JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 12865 | 3% | 1% | 34 |
4 | JOURNAL OF CLINICAL PSYCHIATRY | 10338 | 5% | 1% | 49 |
5 | PSYCHOPHARMAKOTHERAPIE | 7486 | 1% | 2% | 11 |
6 | CNS SPECTRUMS | 7050 | 2% | 1% | 16 |
7 | REVIEWS IN CONTEMPORARY PHARMACOTHERAPY | 5547 | 0% | 4% | 4 |
8 | INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE | 5305 | 1% | 1% | 12 |
9 | JOURNAL OF PSYCHOPHARMACOLOGY | 4689 | 2% | 1% | 19 |
10 | PSYCHOPHARMACOLOGY BULLETIN | 3361 | 1% | 1% | 14 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | VENLAFAXINE | 1627875 | 20% | 25% | 208 | Search VENLAFAXINE | Search VENLAFAXINE |
2 | MILNACIPRAN | 858864 | 8% | 34% | 81 | Search MILNACIPRAN | Search MILNACIPRAN |
3 | DULOXETINE | 832592 | 13% | 21% | 130 | Search DULOXETINE | Search DULOXETINE |
4 | DESVENLAFAXINE | 681050 | 4% | 57% | 39 | Search DESVENLAFAXINE | Search DESVENLAFAXINE |
5 | O DESMETHYLVENLAFAXINE | 643685 | 2% | 83% | 25 | Search O+DESMETHYLVENLAFAXINE | Search O+DESMETHYLVENLAFAXINE |
6 | DULOXETINE HYDROCHLORIDE | 217556 | 1% | 54% | 13 | Search DULOXETINE+HYDROCHLORIDE | Search DULOXETINE+HYDROCHLORIDE |
7 | LEVOMILNACIPRAN | 137628 | 1% | 64% | 7 | Search LEVOMILNACIPRAN | Search LEVOMILNACIPRAN |
8 | SNRI | 121543 | 2% | 18% | 22 | Search SNRI | Search SNRI |
9 | VENLAFAXINE XR | 118823 | 1% | 38% | 10 | Search VENLAFAXINE+XR | Search VENLAFAXINE+XR |
10 | SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITOR | 108134 | 1% | 50% | 7 | Search SEROTONIN+AND+NOREPINEPHRINE+REUPTAKE+INHIBITOR | Search SEROTONIN+AND+NOREPINEPHRINE+REUPTAKE+INHIBITOR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |